Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q/A
Source: 0001731122-25-000254
Chunk: 49

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q/A
Chunk 49
---
 (2,016,328 | ) |     | $ |    (2,777,207 | ) |
| Net Cash Used in Investing Activities     |     |   |             — |   |     |   |    (1,057,875 | ) |
| Net Cash Provided by Financing Activities |     |   |     2,029,183 |   |     |   |     2,562,817 |   |
| Effect of exchange rates on cash          |     |   |       (12,751 | ) |     |   |       (78,741 | ) |
| Change in Cash and Cash Equivalents       |     | $ |           104 |   |     | $ |    (1,351,006 | ) |

Cash Flows

Cash used in operating activities for the three months ended September 30, 2024,
and 2023 was ($2,016,328) and ($2,777,207), respectively, representing a decrease of $760,879. The decrease is primarily related to the
changes in our operating assets and liabilities.

Cash used in investing activities
for the three months ended September 30, 2024, and 2023 was zero and ($1,057,875), respectively. Cash used in investing activities during
the prior period primarily related to the issuance of notes receivable prior to the acquisition of Renovaro Cube totaling $1,057,875.

Cash provided by financing activities
for the three months ended September 30, 2024, was $2,029,183 as compared to cash provided by financing activities of $2,562,817 during
the three months ended September 30, 2023. During the three months ended September 30, 2024, the Company received net proceeds of $156,947
from issuance of notes payable and $2,096,181 from private placements that were partially offset by $223,945 in repayment of a finance
agreement.

Off-Balance Sheet Arrangements

The Company does not have any off-balance
sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes
in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material
to investors.

Significant Accounting Policies and Critical Accounting Estimates

The methods, estimates, and judgments
that we use in applying our accounting policies have a significant impact on the results that